Arrowhead Pharmaceuticals, Inc.

State of Tennessee, Department of Treasury ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

55,642

Value ($000)

3,858

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	3,858	0.0%	55,642	12/31/2025
2025 Q3	11/14/2025	1,881	0.0%	54,550	9/30/2025
2025 Q2	8/15/2025	862	0.0%	54,550	6/30/2025
2025 Q1	5/13/2025	704	0.0%	55,236	3/31/2025
2024 Q4	2/13/2025	578	0.0%	30,748	12/31/2024
2024 Q3	11/14/2024	612	0.0%	31,615	9/30/2024
2024 Q2	8/13/2024	1,956	0.0%	75,248	6/30/2024
2024 Q1	5/14/2024	1,788	0.0%	62,506	3/31/2024
2023 Q4	2/14/2024	1,760	0.0%	57,506	12/31/2023
2023 Q3	11/14/2023	1,814	0.0%	67,506	9/30/2023
2023 Q2	8/15/2023	2,008	0.0%	56,323	6/30/2023
2023 Q1	5/12/2023	1,431	0.0%	56,323	3/31/2023
2022 Q4	2/15/2023	2,434	0.0%	60,000	12/31/2022
2022 Q3	1/26/2023	2,314	0.0%	70,000	9/30/2022
2021 Q2	8/11/2021	9,065	0.0%	109,453	6/30/2021
2021 Q1	5/10/2021	1,953	0.0%	29,453	3/31/2021
2020 Q4	2/9/2021	8,840	0.0%	115,205	12/31/2020
2020 Q1	5/28/2020	1,270	0.0%	44,126	3/31/2020
2019 Q4	2/6/2020	1,903	0.0%	30,000	12/31/2019